Mohammad I. M. Hojouj was honored with the Humanitarian Yvonne Award during the Yvonne Awards Ceremony at OncoDaily Party 2026, held on May 29 at Park West in Chicago.
Natera was the exclusive partner of the Yvonne Awards Ceremony and OncoDaily Reception.
The recognition highlights Dr. Hojouj’s work across clinical oncology, multidisciplinary cancer care, medical education, clinical research, and patient safety. His career reflects a steady commitment to caring for patients with solid tumors, supporting oncology teams, strengthening clinical trial practice, and bringing scientific discipline into everyday cancer care.
The Yvonne Awards, presented by OncoDaily, recognize individuals whose work contributes meaningfully to oncology through service, leadership, research, innovation, and impact. The Humanitarian Yvonne Award honors a professional whose career reflects dedication to patients, clinical responsibility, and the values that keep oncology grounded in human care.
A Career Rooted in Oncology Practice
Mohammad I. M. Hojouj completed his Doctor of Medicine degree in 2012, followed by oncology residency training and specialty certification in oncology. He also obtained a Master of Science in Medical Oncology and a professional PhD certificate in medical oncology, building a strong academic and clinical foundation for his work in cancer care.
His oncology experience spans a broad range of solid tumors, including breast, lung, gynecologic, urologic, and gastrointestinal cancers, as well as hematology. This wide clinical background has shaped his work as a consultant oncologist, educator, clinical researcher, and medical monitor.
Throughout his career, Dr. Hojouj has combined direct patient care with leadership in multidisciplinary oncology teams, clinical research, and treatment pathway development.
Leading Cancer Care Through Multidisciplinary Practice
From 2018 to 2022, Dr. Hojouj served as a Consultant in Oncology at Dnipropetrovsk City Multi-field Clinical Hospital, where he led a 55-bed chemotherapy unit and managed a team of six oncologists. In this role, he carried responsibility for patient care, oncology service coordination, and clinical decision-making across a large cancer care setting.
He also served as Head of the Multidisciplinary Team, reviewing and endorsing treatment pathways for patients with newly diagnosed solid tumors. As a member of the Tumor Board Team, he contributed to decisions for patients with recurrent or progressive disease, helping guide treatment strategies in complex clinical situations.
At the Jewish Medical Clinic, he held consultant-level responsibility for the care and management of patients with solid tumors and supervised staff-grade physicians. These roles reflect a career built not only on medical expertise, but also on accountability, team leadership, and continuity of care.
From Bedside Care to Clinical Research
Dr. Hojouj’s professional work also extends deeply into clinical research. He has 10 years of experience in clinical research, including work as a sub-investigator in local and international clinical trials, as well as experience in Medical Affairs and Safety Services within a clinical research organization.
He has served as a sub-investigator for more than 50 Phase I-II and Phase III clinical studies across solid tumors. His clinical research experience includes study design support, protocol development, medical monitoring, safety review, clinical data interpretation, investigator engagement, and regulatory strategy.
This work places him at an important point between patient care and drug development. In oncology, clinical trials depend on professionals who can understand both the science and the human reality of cancer treatment. Dr. Hojouj’s experience reflects that bridge.
Strengthening Safety and Medical Monitoring in Oncology Trials
Since December 2022, Dr. Hojouj has served as a Senior Clinical Developmental Physician at Simbec-Orion. His responsibilities include acting as a medical monitor for assigned trials, supporting feasibility assessment, protocol design, case report form design, site selection, medical monitoring plans, adverse event management, serious adverse event review, client liaison, and safety committee meetings.
His work also includes reviewing clinical study reports, preparing medical and patient narratives, supporting pharmacovigilance processes, reviewing individual case safety reports, identifying emerging safety concerns, and helping ensure that clinical trials meet relevant ethical and regulatory standards.
In modern oncology, safety oversight is a central part of responsible progress. New treatments can only move forward when clinical development is guided by careful monitoring, scientific judgment, and a clear responsibility to protect patients. Dr. Hojouj’s work in this area represents an essential part of cancer research that often remains behind the scenes but directly affects patient safety.
An Educator Shaping the Next Generation
Alongside his clinical and research work, Dr. Hojouj has contributed to medical education. He served as an Assistant Professor at Dnipro Medical University from 2014 to 2018 and later as an Associate Professor at Dnipropetrovsk Medical University from 2018 to 2022. His academic responsibilities included lecturing medical students and junior doctors in oncology.
This educational role is an important part of his broader contribution. Oncology requires not only experienced physicians, but also teachers who can prepare younger clinicians to understand cancer biology, treatment decision-making, patient communication, and the practical challenges of care delivery.
A Multilingual Oncologist With International Experience
Dr. Hojouj’s professional profile also reflects international adaptability. He is fluent in English, Russian, Ukrainian, and Arabic, and his professional memberships include the UK Royal College of Oncology and Radiology, the British Medical Association, ESMO, ASCO, and ESGO.
His background across clinical practice, academia, oncology trials, medical monitoring, and multilingual communication reflects a physician able to work across systems, teams, and patient populations.
Honoring Service at the Human Center of Oncology
The Humanitarian Yvonne Award recognizes Dr. Mohammad I. M. Hojouj’s commitment to oncology as a field where science and responsibility must remain closely connected. His career has involved direct care for patients with cancer, leadership of chemotherapy services, participation in tumor boards, supervision of medical teams, education of younger doctors, and safety oversight in oncology clinical trials.
At OncoDaily Party 2026, his recognition served as a reminder that humanitarian impact in oncology is often built through daily clinical responsibility: leading teams, protecting patients, supporting research integrity, teaching future physicians, and helping treatment decisions remain thoughtful and patient-centered.
Through his work in clinical oncology, medical education, clinical development, and trial safety, Dr. Hojouj continues to contribute to cancer care with a professional focus grounded in service, discipline, and human responsibility.
Written by Nare Hovhanniyan, MD